Literature DB >> 17544151

Synthesis, spectroscopic and X-ray characterization of a copper(II) complex with the Schiff base derived from pyridoxal and aminoguanidine: NMR spectral studies of the ligand.

Vukadin M Leovac1, Milan D Joksović, Vladimir Divjaković, Ljiljana S Jovanović, Zana Saranović, Andrej Pevec.   

Abstract

A copper(II) complex with the pyridoxal-aminoguanidine (PL-AG) Schiff base adduct, as an organic compound of the very potent biological activity and promising pharmacological importance in the treatment of diabetic complications, has been prepared and characterized. The X-ray structural analysis of the [CuCl2(PL-AG)] complex showed that it has a distorted pseudo-square-pyramidal (4+1) structure with the tridentate ONN Schiff base in the equatorial plane, with the Cu-O(1), Cu-N(1) and Cu-N(3) bond lengths of 1.917(2)A, 1.930(2)A and 1.984(2)A, respectively. The bond length of the equatorial Cu-Cl(1) is 2.279(1)A, while that of the apical Cu-Cl(2) is 2.792(1)A. Pyridoxal fragment is coordinated in its zwitterionic form. In addition to the X-ray structural analysis, the complex was characterized by IR spectrometric, conductometric and magnetic techniques, and the ligand itself by IR, 1H and 13C NMR spectra.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17544151     DOI: 10.1016/j.jinorgbio.2007.04.004

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  2 in total

1.  DFT study of the mechanism of the reaction of aminoguanidine with methylglyoxal.

Authors:  Christian Solís-Calero; Joaquín Ortega-Castro; Alfonso Hernández-Laguna; Francisco Muñoz
Journal:  J Mol Model       Date:  2014-04-05       Impact factor: 1.810

2.  A highly selective pyridoxal-based chemosensor for the detection of Zn(ii) and application in live-cell imaging; X-ray crystallography of pyridoxal-TRIS Schiff-base Zn(ii) and Cu(ii) complexes.

Authors:  Anwar Hussain; Kadarkaraisamy Mariappan; Dawson C Cork; Luke D Lewandowski; Prem K Shrestha; Samiksha Giri; Xuejun Wang; Andrew G Sykes
Journal:  RSC Adv       Date:  2021-10-21       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.